A substantial advancement in blood sugar treatment is emerging with the approval of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, https://annieuvlv418101.azuria-wiki.com/2243857/revolutionary_development_tirzepatide_45mg_for_diabetes_regulation